Tudóstér: Brunyánszki Attila publikációi

Márton, J., Fodor, T., Nagy, L., Vida, A., Kis, G., Brunyánszki, A., Antal, M., Lüscher, B., Bai, P.: PARP10 (ARTD10) modulates mitochondrial function.
PLoS One. 13 (1), e0187789, 2018.

Brunyánszki, A., Szczesny, B., Virág, L., Szabó, C.: Mitochondrial poly(ADP-ribose) polymerase: the Wizard of Oz at work.
Free Radic. Biol. Med. 100 257-270, 2016.

Vida, A., Abdul-Rahman, O., Mikó, E., Brunyánszki, A., Bai, P.: Poly(ADP-ribose) polymerases in aging: friend or foe?.
Curr. Protein Pept. Sci. 17 (7), 705-712, 2016.

Kiss, B., Szántó, M., Szklenár, M., Brunyánszki, A., Marosvölgyi, T., Sárosi, E., Remenyik, É., Gergely, P., Virág, L., Decsi, T., Rühl, R., Bai, P.: Poly(ADP) ribose polymerase-1 ablation alters eicosanoid and docosanoid signaling and metabolism in a murine model of contact hypersensitivity.
Mol. Med. Rep. 11 (4), 2861-2867, 2015.

Szántó, M., Brunyánszki, A., Márton, J., Vámosi, G., Nagy, L., Fodor, T., Kiss, B., Virág, L., Gergely, P., Bai, P.: Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels.
Biochim. Biophys. Acta. Mol. Basis Dis. 1842 (4), 594-602, 2014.

Nagy, L., Docsa, T., Szántó, M., Brunyánszki, A., Hegedűs, C., Márton, J., Kónya, B., Virág, L., Somsák, L., Gergely, P., Bai, P.: Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N'-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism.
PLoS One. 8 (7), e69420-, 2013.

Szántó, M., Brunyánszki, A., Kiss, B., Nagy, L., Gergely, P., Virág, L., Bai, P.: Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein.
Cell. Mol. Life Sci. 69 (24), 4079-4092, 2012.

Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., Yamamoto, H., Huber, A., Kiss, B., Houtkooper, R., Schoonjans, K., Schreiber, V., Sauve, A., Menissier-de, M., Auwerx, J.: PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.
Cell Metab. 13 (4), 461-468, 2011.

Bai, P., Cantó, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., Yamamoto, H., Houten, S., Kiss, B., Oudart, H., Gergely, P., Menissier-de, M., Schreiber, V., Sauve, A., Auwerx, J.: PARP-2 regulates SIRT1 expression and whole-body energy expenditure.
Cell Metab. 13 (4), 450-460, 2011.

Brunyánszki, A., Hegedűs, C., Szántó, M., Erdélyi, K., Kovács, K., Schreiber, V., Gergely, S., Kiss, B., Szabó, É., Virág, L., Bai, P.: Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress.
J. Invest. Dermatol. 130 (11), 2629-2637, 2010.

Bai, P., Hegedűs, C., Szabó, É., Gyüre, L., Bakondi, E., Brunyánszki, A., Gergely, S., Szabó, C., Virág, L.: Poly(ADP-ribose) polymerase mediates inflammation in a mouse model of contact hypersensitivity.
J. Invest. Dermatol. 129 (1), 234-238, 2009.

Juhász, L., Docsa, T., Brunyánszki, A., Gergely, P., Antus, S.: Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.
Bioorg. Med. Chem. 15 (12), 4048-4056, 2007.

Benltifa, M., Vidal, S., Fenet, B., Msaddek, M., Goekjian, P., Praly, J., Brunyánszki, A., Docsa, T., Gergely, P.: In search of glycogen phosphorylase inhibitors: 5-substituted 3-C-glucopyranosyl-1,2,4-oxadiazoles from beta-D-glucopyranosyl cyanides upon cyclization of O-acylamidoxime intermediates.
European J. Org. Chem. 2006 (18), 4242-4256, 2006.

Györgydeák, Z., Hadady, Z., Felföldi, N., Krakomperger, A., Nagy, V., Tóth, M., Brunyánszki, A., Docsa, T., Gergely, P., Somsák, L.: Synthesis of N-(beta-D-glucopyranosyl)- and N-(2-acetamido-2-deoxy-beta-D-glucopyranosyl) amides as inhibitors of glycogen phosphorylase.
Bioorg. Med. Chem. 12 (18), 4861-4870, 2004.